Pfizer Q2 Profit Up 25% Despite Stinging Loss Of Lipitor
- Wednesday, August 1, 2012, 3:00
- Market
- Add a comment
Pfizer says its quarterly profit rose 25%, even as sales of its blockbuster anti-cholesterol drug Lipitor slid further. Still, the pharmaceutical giant completed several steps in new CEO Ian Reed’s plan to focus the company on creating big-ticket drugs.
http://www.forbes.com/sites/abrambrown/2012/07/31/pfizer-q2-profit-up-25-despite-stinging-loss-of-lipitor/
About the Author
admin123 has written 23404 stories on this site.
